Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1988; Volume 33,Issue 3
  • You have access
    Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    J Balzarini, M Baba, R Pauwels, P Herdewijn, S G Wood, M J Robins and E de Clercq
    Molecular Pharmacology March 1988, 33 (3) 243-249;
  • You have access
    Effects of beta-naphthoflavone on insulin receptor binding and protein kinase activity in rat liver and placenta.
    S L Wang, M K Raizada and K T Shiverick
    Molecular Pharmacology March 1988, 33 (3) 250-256;
  • You have access
    Immunochemical studies of the 36-kDa common beta subunit of guanine nucleotide-binding proteins: identification of a major epitope.
    T Zaremba, P Gierschik, M Pines, P Bray, A Carter, R Kahn, C Simons, R Vinitsky, P Goldsmith and A Spiegel
    Molecular Pharmacology March 1988, 33 (3) 257-264;
  • You have access
    Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
    J A Hartley, K Reszka, E T Zuo, W D Wilson, A R Morgan and J W Lown
    Molecular Pharmacology March 1988, 33 (3) 265-271;
  • You have access
    Induction of rat cytochrome P-450 3 and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl.
    H N Yeowell, D J Waxman, G A LeBlanc, P Linko and J A Goldstein
    Molecular Pharmacology March 1988, 33 (3) 272-278;
  • You have access
    The distribution of cytochrome P-450 monooxygenase in cells of the rabbit lung: an ultrastructural immunocytochemical characterization.
    C J Serabjit-Singh, S J Nishio, R M Philpot and C G Plopper
    Molecular Pharmacology March 1988, 33 (3) 279-289;
  • You have access
    The interaction between D-2 dopamine receptors and GTP-binding proteins.
    K Ohara, K Haga, G Berstein, T Haga, A Ichiyama and K Ohara
    Molecular Pharmacology March 1988, 33 (3) 290-296;
  • You have access
    Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
    A C Howlett, M R Johnson, L S Melvin and G M Milne
    Molecular Pharmacology March 1988, 33 (3) 297-302;
  • You have access
    Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    D Hoyer and H C Neijt
    Molecular Pharmacology March 1988, 33 (3) 303-309;
  • You have access
    Elevation of cytoplasmic calcium concentration stimulates hydrolysis of phosphatidylinositol bisphosphate in chick heart cells: effect of sodium channel activators.
    P M McDonough, D Goldstein and J H Brown
    Molecular Pharmacology March 1988, 33 (3) 310-315;
  • You have access
    Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    G N Kooper, N R Levinson, C F Copeland and W D Bowen
    Molecular Pharmacology March 1988, 33 (3) 316-326;
  • You have access
    Stereospecific interaction of tocainide with the cardiac sodium channel.
    R S Sheldon, N J Cannon, A S Nies and H J Duff
    Molecular Pharmacology March 1988, 33 (3) 327-331;
  • You have access
    External location of sites on pig erythrocyte membranes that bind nitrobenzylthioinosine.
    F R Agbanyo, C E Cass and A R Paterson
    Molecular Pharmacology March 1988, 33 (3) 332-337;
  • You have access
    Mechanism of halothane-induced inhibition of isoproterenol-stimulated lipolysis in isolated rat adipocytes.
    P G Prokocimer, M Maze, R G Vickery, F B Kraemer, R Gandjei and B B Hoffman
    Molecular Pharmacology March 1988, 33 (3) 338-343;
  • You have access
    In vivo rat hemoglobin thiyl free radical formation following phenylhydrazine administration.
    K R Maples, S J Jordan and R P Mason
    Molecular Pharmacology March 1988, 33 (3) 344-350;
  • You have access
    The carbon dioxide anion radical adduct in the perfused rat liver: relationship to halocarbon-induced toxicity.
    L B LaCagnin, H D Connor, R P Mason and R G Thurman
    Molecular Pharmacology March 1988, 33 (3) 351-357;
  • You have access
    Inhibition of repair patch ligation by an inhibitor of poly(ADP-ribose) synthesis in normal human fibroblasts damaged with ultraviolet radiation.
    D J Hunting and B J Gowans
    Molecular Pharmacology March 1988, 33 (3) 358-362;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 3
1 Mar 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics